Stockreport

Akcea Reports Financial Results and Highlights for First Quarter 2019

AKCEA THERAPEUTICS  (AKCA) 
Last akcea therapeutics earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.akceatx.com/media-investors/press-releases
PDF Achieved First Quarter 2019 TEGSEDI® (inotersen) Global Net Product Revenues of $7 Million  Novartis exercised its option to license AKCEA-APO(a)-LRx Received marketin [Read more]